
Latent Tuberculosis Infection (LTBI) Testing Industry Research Report 2025
Description
Summary
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
According to APO Research, The global Latent Tuberculosis Infection (LTBI) Testing market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile and Bio-Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection (LTBI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing.
The Latent Tuberculosis Infection (LTBI) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Latent Tuberculosis Infection (LTBI) Testing Segment by Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Latent Tuberculosis Infection (LTBI) Testing Segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI) Testing Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Latent Tuberculosis Infection (LTBI) Testing Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Latent Tuberculosis Infection (LTBI) Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection (LTBI) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection (LTBI) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection (LTBI) Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
According to APO Research, The global Latent Tuberculosis Infection (LTBI) Testing market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Latent Tuberculosis Infection (LTBI) Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile and Bio-Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection (LTBI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing.
The Latent Tuberculosis Infection (LTBI) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Latent Tuberculosis Infection (LTBI) Testing Segment by Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Latent Tuberculosis Infection (LTBI) Testing Segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI) Testing Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Latent Tuberculosis Infection (LTBI) Testing Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Latent Tuberculosis Infection (LTBI) Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection (LTBI) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection (LTBI) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection (LTBI) Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
132 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Latent Tuberculosis Infection (LTBI) Testing by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 Tuberculin Skin Test (TST)
- 2.2.3 Interferon Gamma Released Assay (IGRA)
- 2.3 Latent Tuberculosis Infection (LTBI) Testing by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Hospitals and Clinics
- 2.3.3 Diagnostic Laboratories
- 2.3.4 Others
- 2.4 Assumptions and Limitations
- 3 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type
- 3.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2020-2025)
- 3.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031)
- 4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application
- 4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2020-2025)
- 4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2020-2031)
- 5.2 Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Region
- 5.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Region (2020-2025)
- 5.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2026-2031)
- 5.3 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
- 5.3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
- 5.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
- 5.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
- 5.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue
- 6.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2020-2025)
- 6.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2025)
- 6.2 Global Latent Tuberculosis Infection (LTBI) Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head Office and Area Served
- 6.4 Global Latent Tuberculosis Infection (LTBI) Testing Players, Product Type & Application
- 6.5 Global Latent Tuberculosis Infection (LTBI) Testing Manufacturers Established Date
- 6.6 Global Latent Tuberculosis Infection (LTBI) Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
- 7.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
- 7.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
- 8.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
- 8.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
- 9.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
- 10.2 South America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
- 10.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
- 11.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 Qiagen
- 12.1.1 Qiagen Company Information
- 12.1.2 Qiagen Business Overview
- 12.1.3 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.1.5 Qiagen Recent Developments
- 12.2 Sanofi
- 12.2.1 Sanofi Company Information
- 12.2.2 Sanofi Business Overview
- 12.2.3 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.2.5 Sanofi Recent Developments
- 12.3 Oxford Immunotec
- 12.3.1 Oxford Immunotec Company Information
- 12.3.2 Oxford Immunotec Business Overview
- 12.3.3 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.3.5 Oxford Immunotec Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 Par Sterile
- 12.5.1 Par Sterile Company Information
- 12.5.2 Par Sterile Business Overview
- 12.5.3 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.5.5 Par Sterile Recent Developments
- 12.6 Bio-Rad Laboratories
- 12.6.1 Bio-Rad Laboratories Company Information
- 12.6.2 Bio-Rad Laboratories Business Overview
- 12.6.3 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
- 12.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 12.6.5 Bio-Rad Laboratories Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.